Details
 

November 16, 2021
5:45PM - 8:00PM

Precision Medicine Oncology Symposium: From the Basics to Current Clinical Applications

Part 2

A Virtual Event

Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of genome sequencing and genomic profiling has significantly improved the diagnoses and treatment of oncologic diseases by identifying unique variants that can be targeted with gene-based targeted therapeutic approaches, including immunotherapies.

The series is designed to provide oncology clinicians and researchers foundational information on the latest technologies available for data acquisition, diagnosis, and decision-making for oncologic diseases.

Part 2 Topics Include

  • Liquid Biopsy: Advantages and Limitations  
    • Geoff Oxnard, MD
      Foundation Medicine

  • Germline Mutations and Hereditary Cancers
    • Elena Stoffel, MD, MPH
      University of Michigan

  • Tumor Board Case Session
    • Breast
      • Lynn Henry, MD, PhD
        University of Michigan
    • GU
      • Clara Hwang, MD
        Henry Ford

Continuing Education
No CME credits will be awarded for this session. 

Click Here to Register Today!

Be sure to also register for Part 1 of this series on November 4! 

Printer-Friendly Version


Add to Calendar aCLuDhaqizCaPxAftmqF167204 11/16/2021 05:45 PM 11/16/2021 08:00 PM false Precision Medicine Oncology Symposium: From the Basics to Current Clinical Applications Precision medicine encompasses all approaches that use patient- and disease-specific information to prevent, diagnose, and treat a disease. The increasingly widespread use of genome sequencing and genomic profiling has significantly improved the diagnoses and treatment of oncologic diseases by identifying unique variants that can be targeted with gene-based targeted therapeutic approaches, including immunotherapies. The series is designed to provide oncology clinicians and researchers foundational information on the latest technologies available for data acquisition, diagnosis, and decision-making for oncologic diseases. Part 2 Topics Include Liquid Biopsy: Advantages and Limitations   Geoff Oxnard, MDFoundation Medicine Germline Mutations and Hereditary Cancers Elena Stoffel, MD, MPHUniversity of Michigan Tumor Board Case Session Breast Lynn Henry, MD, PhDUniversity of Michigan GU Clara Hwang, MDHenry Ford Continuing EducationNo CME credits will be awarded for this session.  Click Here to Register Today! Be sure to also register for Part 1 of this series on November 4!  A Virtual Event

Report Broken Links

Have you encountered a problem with a URL (link) on this page not working or displaying an error message? Help us fix it! 
Report Broken Link